Herve Bischoff

Strasbourg, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

NF-κB signaling drives rapid skeletal muscle atrophy in patients with breast cancer: the cost of fighting cancer with chemotherapy.

NF-κB signaling drives rapid skeletal muscle atrophy in patients with breast cancer: the cost of fighting cancer with chemotherapy.

Journal: American journal of physiology. Cell physiology
Published: April 16, 2026

Impairments in mitochondrial dynamics and morphology in skeletal muscle of breast cancer patients after a single paclitaxel administration.

Impairments in mitochondrial dynamics and morphology in skeletal muscle of breast cancer patients after a single paclitaxel administration.

Journal: Experimental physiology
Published: April 09, 2026

Effectiveness of pegylated liposomal doxorubicin (Caelyx®) monotherapy in patients with metastatic HER2-low breast cancer: a monocentric retrospective study.

Effectiveness of pegylated liposomal doxorubicin (Caelyx®) monotherapy in patients with metastatic HER2-low breast cancer: a monocentric retrospective study.

Journal: Cancer treatment and research communications
Published: December 23, 2025

Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review.

Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review.

Journal: Current oncology (Toronto, Ont.)
Published: October 15, 2025

Feasibility and Potential Effects of Exercise Training Combining Eccentric and Concentric Cycling in Patients With Breast Cancer.

Feasibility and Potential Effects of Exercise Training Combining Eccentric and Concentric Cycling in Patients With Breast Cancer.

Journal: European journal of sport science
Published: October 09, 2025

Optimizing Post-Neoadjuvant Treatment in Early Triple-Negative Breast Cancer.

Optimizing Post-Neoadjuvant Treatment in Early Triple-Negative Breast Cancer.

Journal: Cancers
Published: August 28, 2025

CDK4/6 Inhibitors in HER2-positive Metastatic Breast Cancer.

CDK4/6 Inhibitors in HER2-positive Metastatic Breast Cancer.

Journal: Clinical breast cancer
Published: June 19, 2025

First Report of SPECC1L::ALK Fusion in Medullary Thyroid Carcinoma with Remarkable Response to Alectinib.

First Report of SPECC1L::ALK Fusion in Medullary Thyroid Carcinoma with Remarkable Response to Alectinib.

Journal: Thyroid : official journal of the American Thyroid Association
Published: May 16, 2025

Comparative Preclinical Evaluation of Tuznue Versus Referent Herceptin: A Registered Trastuzumab Biosimilar.

Comparative Preclinical Evaluation of Tuznue Versus Referent Herceptin: A Registered Trastuzumab Biosimilar.

Journal: Drugs in R&D
Published: March 11, 2025

Case report: Long-term response to a combination of immune checkpoint inhibitors as a single treatment for multiple synchronous cancers: a case study.

Case report: Long-term response to a combination of immune checkpoint inhibitors as a single treatment for multiple synchronous cancers: a case study.

Journal: Frontiers in immunology
Published: August 27, 2024

Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer.

Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer.

Journal: Current treatment options in oncology
Published: July 25, 2024

Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer.

Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer.

Journal: Current treatment options in oncology
Published: July 25, 2024
Showing 1-12 of 14

Last Updated: 09/26/2026